Earlier this month, Exact reported a record $851 million in third-quarter revenue, which included $666 million from its screening business.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
J&J this year lost its patent exclusivity for Stelara, its longtime top-selling drug that treats psoriasis and inflammatory bowel disease.
AI functions as a sidekick in healthcare labs, but it can make a huge difference by accelerating drug development and boosting data accuracy.
Microsoft wants to patent a system that thinks, acts and checks its results while handling patient data and working within hospital systems.
Pangaea Data’s new platform aims to improve medical treatments by informing doctors of patients’ health histories and potential diagnoses.
Studies exploring whether there’s a connection between Tylenol’s key ingredient acetaminophen and autism have had mixed results.
About 5 million people are affected by idiopathic pulmonary fibrosis globally, according to the National Institutes of Health.
Most major brands in cereal, snacks, and drinks are putting out announcements about how they’re aligning with MAHA guidelines.
This patent isn’t the first time we’ve seen AI make inroads into healthcare.
Cyber-criminals often see healthcare firms’ shoddy protection as a “pot of gold.”
While virtual care boomed during the pandemic, the sector more recently had an up-and-down couple of years as the world returned to normalcy.
Moderna is counting on revenue from newer mRNA vaccines, including a next generation Covid shot, to make up for falling sales.
One high-profile early adopter: Swiss bank UBS, which is turning its army of investment banking analysts into AI avatars.
Just over 70% of Americans say they don’t want to live to be centenarians, afraid they won’t be able to afford the costs of longevity.
US President Donald Trump is reportedly considering linking prescription drug prices to their price tags in other developed nations.
“There’s just so many ways you can leverage that data, and it’s relatively easy to get.”